Literature DB >> 23149387

Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation.

John P Iredale1, Alexandra Thompson, Neil C Henderson.   

Abstract

Fibrosis is a highly conserved wound healing response and represents the final common pathway of virtually all chronic inflammatory injuries. Over the past 3 decades detailed analysis of hepatic extracellular matrix synthesis and degradation using approaches incorporating human disease, experimental animal models and cell culture have highlighted the extraordinarily dynamic nature of tissue repair and remodelling in this solid organ. Furthermore emerging studies of fibrosis in other organs demonstrate that basic common mechanisms exist, suggesting that bidirectionality of the fibrotic process may not solely be the preserve of the liver. In this review we will examine the cellular and molecular mechanisms that govern extracellular matrix degradation and fibrosis resolution, and highlight how manipulation of these processes may result in the development of effective anti-fibrotic therapies. This article is part of a Special Issue entitled: Fibrosis: Translation of basic research to human disease.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23149387     DOI: 10.1016/j.bbadis.2012.11.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  72 in total

Review 1.  Natural regression of fibrosis in chronic hepatitis B.

Authors:  Shogo Ohkoshi; Haruka Hirono; Kazuhiko Watanabe; Katsuhiko Hasegawa; Kenya Kamimura; Masahiko Yano
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

Review 2.  Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology.

Authors:  Ralf Weiskirchen; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

Review 3.  Antifibrotic therapies in the liver.

Authors:  W Z Mehal; D Schuppan
Journal:  Semin Liver Dis       Date:  2015-05-14       Impact factor: 6.115

4.  Vascular endothelial growth factor promotes fibrosis resolution and repair in mice.

Authors:  Liu Yang; Junghee Kwon; Yury Popov; Gabriella B Gajdos; Tamas Ordog; Rolf A Brekken; Debabrata Mukhopadhyay; Detlef Schuppan; Yan Bi; Douglas Simonetto; Vijay H Shah
Journal:  Gastroenterology       Date:  2014-02-04       Impact factor: 22.682

5.  Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years.

Authors:  Pallavi Surana; Devika Kapuria; Carly Broadwell; Elizabeth C Wright; Varun Takyar; David E Kleiner; Marc G Ghany; Gil Ben-Yakov; Theo Heller; T Jake Liang; Christopher Koh
Journal:  Antiviral Res       Date:  2019-05-21       Impact factor: 5.970

6.  Regulation of type I collagen expression by microRNA-29 following ionizing radiation.

Authors:  Hiroyuki Yano; Ryoji Hamanaka; Miki Nakamura-Ota; Juan Juan Zhang; Noritaka Matsuo; Hidekatsu Yoshioka
Journal:  Radiat Environ Biophys       Date:  2017-12-11       Impact factor: 1.925

7.  Substrate stiffness regulates primary hepatocyte functions.

Authors:  Vaishaali Natarajan; Eric J Berglund; Dorothy X Chen; Srivatsan Kidambi
Journal:  RSC Adv       Date:  2015-09-14       Impact factor: 3.361

8.  Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Semin Liver Dis       Date:  2020-04-02       Impact factor: 6.115

Review 9.  Type 2 immunity in tissue repair and fibrosis.

Authors:  Richard L Gieseck; Mark S Wilson; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

Review 10.  New approaches for fibrosis regression in alcoholic cirrhosis.

Authors:  Wajahat Mehal; Uyen To
Journal:  Hepatol Int       Date:  2016-07-26       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.